Burzynski Research Institute Partners with Premier Research to …
The News Review:
- Burzynski Research Institute Partners with Premier Research to …
- HSU Knight Cancer Institute welcomes Lung Cancer Specialist
- NIH awards Case Western Reserve University $1.33M
- Rem Medical acquires PsyPharma Tucson
- DR BioPharma Announces Appointment of Christopher J. Schaber PhD …
- PHC Signs Final Agreement for Sale of Pivotal to Premier Research
- 911 ER Slower to Respond to Women’s Heart Attacks
Burzynski Research Institute Partners with Premier Research to …
MarketWatch (press release)
Premier Research delivers high quality clinical trial services for biopharmaceutical and medical device companies and has a successful track record providing services for covering a wide spectrum of cancer-related therapeutic indications. Premier Research’s oncology expertise ranges from small dose findings and proof-of-concept studies to large multi-national Phase III trials and as such is well suited to partner with BRI on this study. In addition to oncology the company leads in the management of clinical research for analgesia CNS and infectious disease and has deep experience in medical device and pediatric research. Premier Research maintains a well-established network of dedicated clinical sites with 30 offices and operations in more than 30 countries throughout North America and Europe. Burzynski Research Institute Inc.
HSU Knight Cancer Institute welcomes Lung Cancer Specialist
Media Newswire (press release) NY
He received his medical degree at Rush Medical College in Chicago and completed his residency and medical oncology fellowship at Yale University School of Medicine in New Haven Conn. Sandler will join HSU in March. Also joining the HSU Knight Cancer Institute is David M.
Related from Cnurology: Cancer expert to head HSU urology division
NIH awards Case Western Reserve University $1.33M
EurekAlert (press release) DC
the co-principal investigator from the Case School of Engineering includes investigators from the Marshfield Clinic University of Wisconsin Madison and the University of Michigan. This team will develop Multi-Modality Multi-Resource Environment for Physiological and Clinical Research (Physio-MIMI) an informatics infrastructure for collecting managing and analyzing diverse data types across institutions. “The software developed will provide easier collaboration between investigators from diverse disciplines and help them better address complex health problems that affect multiple aspects of health such as the heart brain (sleep) and genomic data” said Redline. “By enhancing the ability of investigators to access combine and analyze research information from physiological testing questionnaires and other sources the hope is that novel markers of disease will be identified leading to new approaches for screening diagnosing and treating illnesses. Researchers will be able to more effectively and efficiently collaborate in national studies that include many complex data sources and types such as heart or brain monitoring data and genomic information. A key component of the system will allow secure safe and regulated transfer of information from clinical care systems and research databases.
Rem Medical acquires PsyPharma Tucson
Pharmaceutical Business Review
As part of the acquisition Rem retained an exceptional investigative clinical and administrative team with a track record of quality trial activity. Derek Loewy has been involved as the principal investigator in over thirty clinical trials since completing his sleep medicine fellowship training at Stanford in 2001. Prior to PsyPharma Dr Loewy was the director of the insomnia program at the Sleep Clinic of San Francisco. Russell Benaroya CE of Rem Medical said: “We are thrilled to be working with Dr Loewy and his research team.
DR BioPharma Announces Appointment of Christopher J. Schaber PhD …
MarketWatch (press release)
Prior to joining DR Dr. Schaber served from 1998 to 2006 asExecutive Vice President and Chief perating fficer of DiscoveryLaboratories Inc. where he was responsible for overall pipelinedevelopment and key areas of commercial operations includingregulatory affairs quality control and assurance manufacturing anddistribution preclinical and clinical research and medical affairsas well as coordination of commercial launch preparation activities. During his tenure at Discovery Laboratories Inc. he played asignificant role in raising in excess of $160 million through bothpublic offerings and private placements. From 1996 to 1998 Dr. Schaber was a co-founder of Acute Therapeutics Inc.
PHC Signs Final Agreement for Sale of Pivotal to Premier Research
CNNMoney.com
The company focuses its research anddevelopment program on enhancing software systems used to support itsclinical trials management and information services. Its services includededicated clinical sites medical and safety management medical writingdata management biostatistics interactive voice response systemsregulatory affairs and quality assurance. The company conducts itsclinical research in the areas of infectious diseases oncologypediatrics analgesia and central nervous disorders. Premier ResearchGroup plc was founded in 2002 and is based in Crowthorne the UnitedKingdom. The company also offers internet and telephonic-based referralservices that includes employee assistance programs and critical incidentservices.
911 ER Slower to Respond to Women’s Heart Attacks
MedHeadlines IL
Instead women may experience nausea and vomiting back and jaw pain profuse sweating and pain in both arms. With symptoms that mimic gastroenteritis emergency services personnel are sometimes slower getting a woman suffering a heart attack to a hospital than they are a man suffering a heart attack. Thomas Concannon assistant professor of medicine at Boston’s Institute for Clinical Research and Health Policy Studies at Tufts Medical Center authored the report on speedy treatment of women’s initial symptoms of heart attack published in the January 14 issue of the journal ‘Circulation: Cardiovascular Quality and utcomes. ’ He says his study did not explain why the delay in treatment occurs but suggests the inability to recognize the symptoms as associated with heart attack on the parts of both the patient and the response team. Concannon’s research team studied 5887 calls to emergency medical services (EMS) when symptoms of cardiac distress were suspected. These EMS calls occurred in 10 municipalities in Dallas County Texas in 2004 and involved 29 hospitals and 98 EMS dispatch depots. n average women were slower to arrive at hospitals by an average of 2.
Written by admin on January 27th, 2009 with
no comments.
Read more articles on News.